Sfoglia per AUTORE
VITA D
Collezione ASL Asti

  

Items : 5

2024
ASL Asti
AOU Città della Salute di Torino

Shbaklo N; Cerutti A; Curtoni A; Gregorc V; Crisà E; Caravelli D; Busca A; Vita D; Carnevale-Schianca F; Lupia T; Corcione S; De Rosa FG;

Sequential or Combination Treatments as Rescue Therapies in Immunocompromised Patients with Persistent SARS-CoV-2 Infection in the Omicron Era: A Case Series. in Antibiotics (Basel, Switzerland) / Antibiotics (Basel). 2023 Sep 19;12(9):1460. doi: 10.3390/antibiotics12091460.
2023
ASL Asti
ASL Città di Torino

Calcagno A; Bonora S; De Rosa FG; Gregorc V; Frascione PMM; Allice T; Ponzetta L; Vita D; Pepe A; Lupia T; Ranzani FA; Gaviraghi A; Venuti F; Longo BM;

Cefiderocol use in Gram negative infections with limited therapeutic options: Is combination therapy the key? in Journal of infection and public health / J Infect Public Health. 2022 Sep;15(9):975-979. doi: 10.1016/j.jiph.2022.07.006. Epub 2022 Jul 21.
2022
ASL Asti
AOU Città della Salute di Torino

Brazzi L; De Rosa FG; Montrucchio G; Vita D; Lupia T; Corcione S; De Benedetto I; Pinna SM;

Pharmacokinetic of Cefiderocol in Critically Ill Patients Receiving Renal Replacement Therapy: A Case Series. in Antibiotics (Basel, Switzerland) / Antibiotics (Basel). 2022 Dec 16;11(12):1830. doi: 10.3390/antibiotics11121830.
2022
ASL Asti
ASL Città di Torino
AOU Città della Salute di Torino

De Rosa FG; Di Perri G; D'Avolio A; Mula J; Lupia T; Vita D; De Benedetto I; Scabini S; De Nicolò A; Montrucchio G; Mornese Pinna S; Corcione S;

Monoclonal antibodies for the treatment of COVID-19 patients: An umbrella to overcome the storm? in International immunopharmacology / Int Immunopharmacol. 2021 Dec;101(Pt A):108200. doi: 10.1016/j.intimp.2021.108200. Epub 2021 Sep 28.
2021
ASL Asti
AOU Città della Salute di Torino

De Rosa FG; Cattel F; Varese A; Colasanto I; Gaviraghi A; De Benedetto I; Vita D; Scabini S; Mornese Pinna S; Lupia T; Corcione S;